In a different approach, but also focusing on CD4+ T cells, the group of Amy E. Lovett-Racke found that miR-128 and miR-27b were increased in naïve and miR-340 in memory CD4+ T cells from MS patients. Here, CD4 is linked to myeloid sarcoma.